Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2009
10/14/2009CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
10/14/2009CN101554383A Chinese traditional medicine composition for preventing and curing infectious laryngotracheitis of birds
10/14/2009CN101554380A Drug for preventing and curing H1N1 flu virus by adopting 4 (3H) quinazolone
10/14/2009CN101554376A High-bioavailability rapamycin composition and preparation method thereof
10/14/2009CN101554362A Composition of natural product and preparation thereof
10/14/2009CN101554234A Extract of American cranberry and use thereof
10/14/2009CN101554203A Biological feed
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548991C Compound in 4,4-dibasic-3,4-dihydro-2(1H) quinazolone category
10/14/2009CN100548385C Brucellosis nucleic acid vaccine
10/14/2009CN100548384C Genetic engineering polypeptide vaccine adjuvant for aftosa, preparation method and application thereof
10/14/2009CN100548357C Medicine for quickly treating high fever due to tuberculosis and pneumonitis and its preparing method
10/14/2009CN100548355C Medicine for treating dog parvovirus disease
10/14/2009CN100548340C Medicine for treating dog infectious hepatitis
10/14/2009CN100548331C Compound cape-jasmine salted-fermented beans total extract and its preparation and use
10/14/2009CN100548322C An anti-tumor pharmaceutical composition and preparation method thereof
10/14/2009CN100548309C Stavudine sustained release tablet
10/14/2009CN100548305C Compound vibramycin injection for animals and the preparing method thereof
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548301C Injection for curing diarrhea of pig and preparation thereof
10/14/2009CN100548295C Aztreonam liposomes freeze-dry preparations and method of preparing the same
10/14/2009CN100548285C Terbinafine nano milk antifungal medicine and its preparation
10/14/2009CN100548273C Instant cordate houttuynia gel preparation for eye
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601735 Antiviral compounds
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/13/2009US7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601347 Methods and compositions for controlled release of bioactive compounds
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2449572C 4'-substituted nucleosides
10/13/2009CA2419471C Use of triazinetrione sulphones for controlling coccidioses
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2373867C Compositions comprising organosiloxane resins for delivering oral care substances
10/13/2009CA2351463C Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
10/13/2009CA2321265C Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
10/13/2009CA2319515C Anhydrous topical skin preparations
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2234263C Pharmaceutical composition for treating papillomavirus tumours and infection
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/09/2009CA2659498A1 American cranberry extract and use
10/08/2009WO2009124184A2 Methods of activating rnase l
10/08/2009WO2009124175A1 Formulations comprising a phosphoindole compound and one or more second active agents
10/08/2009WO2009123588A1 Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis
10/08/2009WO2009123575A1 A photosensitising composition and its uses
10/08/2009WO2009123480A1 Anti-infective agents and uses thereof
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123304A1 Fine granules having improved suspension performance in water
10/08/2009WO2009123207A1 Oral rinse composition
10/08/2009WO2009123183A1 Antiviral agent and antiviral composition
10/08/2009WO2009123169A1 Amide derivative-containing pharmaceutical composition
10/08/2009WO2009123119A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009WO2009123099A1 Aqueous liquid containing gatifloxacin
10/08/2009WO2009123098A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
10/08/2009WO2009122719A1 Substance and composition both capable of imparting heat resistance
10/08/2009WO2009122223A1 Zeolite formulation and use thereof for the prevention and therapy of diseases caused by infections with herpes simplex virus type 1 and type 2
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009121914A1 Substituted piperidines as therapeutic compounds
10/08/2009WO2009121483A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009WO2009121303A1 Pharmaceutically acceptable salts of anti-infective quinolone compound
10/08/2009WO2009121219A1 An use of arsenide for the preparation of antiviral drugs
10/08/2009WO2009121218A1 The use of mercurid in formulating antiviral medicine
10/08/2009WO2009121183A1 Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
10/08/2009WO2009102715A3 Peptide therapy for ocular herpes infections
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253771 Inhibition of gliotoxin
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253741 Alkene piperidine derivatives as antiviral agents
10/08/2009US20090253732 Production Of Polyketides And Other Natural Products
10/08/2009US20090253726 Tri-, tetra-substituted-3-aminopyrrolidine derivative
10/08/2009US20090253722 Aqueous pharmaceutical formulation
10/08/2009US20090253696 Substituted pyrido(3,2-d) pyrimidines and pharmaceutical compositions for treating viral infections
10/08/2009US20090253692 Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate
10/08/2009US20090253681 HIV Integrase Inhibitors
10/08/2009US20090253671 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
10/08/2009US20090253660 Minocycline Compounds and Methods of Use Thereof
10/08/2009US20090253650 Teat antiseptic prepared from polysaccharide gel with bactericidal and immuno-stimulating activity isolated from durian fruit-rind
10/08/2009US20090253648 Tricyclic-Nucleoside Compounds for Treating Viral Infections
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009US20090253636 Novel Antifungal Agent
10/08/2009US20090253633 Novel Combinations of DNAK Inhibitors With Known Antibacterial Agents
10/08/2009US20090253624 Pharmacologically active antiviral peptides and methods of use
10/08/2009US20090253208 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/08/2009US20090252815 Pulverulent mixtures containing hydrogen peroxide and hydrophobized silicon dioxide
10/08/2009US20090252775 Virucidal disinfectant
10/08/2009US20090252766 Attenuated gram negative bacteria
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252757 Methods and compositions for inhibiting hiv infection
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 1798